Skip to main content
EPFL researchers developed a room-temperature 3D printing process using enzyme-driven mineralization to create bone scaffolds that become load-bearing within 7 days.
Technology
1 min read

EPFL researchers developed a room-temperature 3D printing process using enzyme-driven mineralization to create bone scaffolds that become load-bearing within 7 days.

Originally reported by VoxelMatters

EPFL researchers developed a room-temperature 3D printing process using enzyme-driven mineralization to create bone scaffolds that become load-bearing within 7 days. By replacing high-heat sintering with alkaline phosphatase catalysis, the team achieved 50% porosity mimicking human trabecular bone strength. This biocatalytic approach allows the direct integration of bioactive proteins and living cells into injectable inks. It marks a shift toward energy-efficient AM that could drastically shorten recovery times for fracture patients. 🦴 #3DPrinting #Bioprinting #EPFL #MedTech #AdditiveManufacturing

Read Original

How This Connects

6 related events
  1. Same pattern

    Nuopu Regenerative Medicine receives Class III medical device registration for AM-extruded bone filler

  2. Same pattern

    Cyfuse partners with Keio University and Fujita Health University for 3D bioprinted knee joint clinical trials

  3. Same pattern

    Beijing Institute of Technology researchers Dr.

  4. Same pattern

    Aspect Biosystems secures $280M to scale bioprinted tissue therapy production in Canada.

  5. This article

    EPFL researchers developed a room-temperature 3D printing process using enzyme-driven mineralization to create bone scaffolds that become load-bearing within 7 days.

  6. Same pattern

    Auxilium Biotechnologies is partnering with Starlab Space to deploy the AMP-1 bioprinting platform for scalable medical manufacturing in low Earth orbit.

  7. Same pattern

    PrintBio has joined a federal consortium led by WFIRM to receive up to 24.8 million USD from ARPA-H for bioprinting vascularized kidney tissue.